Kinetics of human cytomegalovirus (HCMV) DNAemia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay.

Background: Consensus human cytomegalovirus (HCMV) DNA cut-off values for preemptive therapy in transplant recipients have not yet been defined, mainly due to the lack of real-time PCR standardization. Objectives: (i) To compare the kinetics of HCMV DNA in transplanted patients using an in-house real-time PCR assay (Pavia assay) and the new Abbott RealTime CMV assay; (ii) to verify assay concordance in the identification of patients eligible for preemptive treatment and (iii) standardize results with international units (IUs) using the WHO International HCMV DNA Standard as a reference. Study design: The kinetics of HCMV disseminated infection was retrospectively evaluated in 513 stored whole blood samples from 37 transplanted patients enrolled in randomized prospective studies designed for the clinical validation of HCMV DNA cut-off values. Conversion factors of HCMV DNA copy number to WHO international units (IUs) were determined. Results: Among the 513 samples, 352 (68.6%) were concordant positive, 42 (8.1%) concordant negative and 119 (23.1%) discordant. All discordant samples resulted positive by the Abbott RealTime CMV assay and negative by the Pavia assay, showing higher sensitivity for the Abbott RealTime CMV assay. A significant correlation was observed between concordant positive samples (r = 0.89). HCMV DNAemia determined by each assay showed overlapping kinetics. Expression of results as IU/ml provided the best results in preemptive treatment simulation. Conclusion: HCMV DNAemia cut-off values determined using our in-house assay and expressed as IU/ml appear valid for use in commercial assays as well as other potential in-house assays

[Primary non-Hodgkin's lymphoma of the breast. Clinico-pathologic study of 2 cases]

The authors describe two cases of malignant non-Hodgkin's lymphoma in a mammary site observed at IRCCS Policlinico San Matteo (Pavia). Histologic, immunohistochemical and clinical features are illustrated. Correct diagnosis is essential so that appropriate multidisciplinary treatment may be applie

Sustainable feed formulation to community‐based aquaculture: Oreochromis niloticus fingerlings performance and antioxidant status

Abstract Community‐based aquaculture can reduce dependence on natural resources, promote biodiversity conservation, and improve local economies and food security. However, this activity is highly dependent on local conditions regarding natural resources, such as the availability of produced organisms, adequate feeds, and environmental factors. As ectothermic organisms, fish are more susceptible to temperature fluctuations in culture conditions. A set of raw ingredients (e.g., cassava and local beans) produced or available in villages from Cabo Delgado (Mozambique) with nutritional potential for fish feed were selected to produce an experimental diet. The following objectives were defined: (1) evaluate growth performance of tilapia fingerlings fed a diet produced with local ingredients, compared with a commercial‐like diet; and (2) evaluate the response to thermal stress (18, 26, and 32°C) by tilapia fingerlings fed with tested diets. Tilapia fed with an experimental diet presented lower growth rates, lower DNA damage, higher neurophysiological, and antioxidant activity, leading to increased oxidative stress. Regarding energy budget, tilapia fed with the experimental diet presented higher protein content at 26°C and lipids at 18°C, leading to greater energy available at these temperatures. Overall, local ingredients can be successfully used as an additional feed source for tilapia production in community‐based aquaculture in earthen ponds

Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants.

Bronchopulmonary dysplasia (BPD) is a chronic lung disease occurring in very and extremely preterm infants undergoing mechanical ventilation. Given the altered lung vascular growth characterizing BPD, circulating angiogenic cells could be useful biomarkers to predict the risk. The objective of the study was to determine whether the percentages of circulating angiogenic cells (CD34+VEGFR-2+, CD34+CD133+VEGFR-2+, and CD45-CD34+CD133+VEGFR-2+ cells), assessed in the peripheral blood at birth by flow cytometry, could be used as markers for the risk of BPD. In one-hundred and forty-two preterm neonates (gestational age less than 32 weeks and/or birth weight less than 1500 g) admitted to our tertiary care Neonatal Intensive Care Unit between 2006 and 2009, we evaluated the percentages of circulating angiogenic cells at birth, at 7 days, and, in a subset of infants (n=40), at 28 days of life. The main outcome was the correlation between cell counts at birth and the subsequent risk of developing BPD. In our study, all the three cell populations failed to predict the development of BPD or other diseases of prematurity. We suggest that these cells cannot be used as biomarkers in preterm infants, and that research is needed to find other early predictors of BPD